Skip to menu Skip to content Skip to footer

Follow-up of patients with progressive multiple sclerosis treated with autologous Epstein Barr virus-specific T cell therapy (2018-2020)

Experts

Emeritus Professor Michael Pender

Emeritus Professor
Royal Brisbane Clinical Unit
Faculty of Medicine
Michael Pender
Michael Pender